- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06817642
Predicting Language Recovery in Acute Stroke Patients in the Neurovascular Intensive Care Unit: An Exploratory Study With the Core Assessment of Language Processing. (PREDICT-CALAP)
Introduction:
Stroke affects one person every 4 minutes in France (i.e. more than 140,000 new cases per year) resulting in cognitive and motor disorders. Aphasia is one of the most devastating cognitive disorders that persist in the late phase. However, early treatment of aphasia can improve the effects of rehabilitation.
Identifying, as early as possible, the patients most at risk of presenting persistent language disorders in the late phase would make it possible to improve their management and increase the effects of cognitive rehabilitation on their language abilities.
The aim of this project is to evaluate whether the Core Assessment of Language Processing (CALAP) assessed in the acute phase of stroke can predict language abilities in the late phase.
Hypothesis/Objective:
The primary objective is to determine whether the language abilities of patients in the acute phase of stroke can be used to predict language abilities in the late phase. Secondary objectives are to determine whether prediction can be improved with (1) brain MRI data and (2) neuropsychological assessment data. The (3) secondary objective is to determine whether cognitive abilities at the chronic phase can be predicted by language performance in the acute phase. The (4) secondary objective is to assess whether language rehabilitation modifies the predictive power of the language abilities assessed with the CALAP.
Method:
Patients will be included during their hospitalization after a brain vascular injury (acute phase, up to 21 days of hospitalization). After discharge, they will return for a post-stroke assessment between 3 and 18 months after the acute phase.
During these two visits, a clinical and neurological examination, a neuropsychological assessment and an MRI will be performed.
A prediction model (development and validation) will be used for all objectives using a linear regression model with cross validation. The entire sample consists of stroke patients.
The study is single-center and will have a total duration of 6 years with an estimated 570 patients included.
Conclusion:
Predicting the language abilities of a post-stroke patient will improve clinical management and direct patients requiring language rehabilitation to appropriate care.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Anne-Catherine BACHOUD-LEVI, MD, PhD
- Phone Number: 0033 01 49 81 43 01
- Email: anne-catherine.bachoud-levi@aphp.fr
Study Contact Backup
- Name: Tiffany MONNIER, MD, PhD
- Phone Number: 0033 01 45 17 84 86
- Email: tiffany.monnier@aphp.fr
Study Locations
-
-
-
Créteil, France, 94010
- Recruiting
- Assistance Publique Hôpitaux de Paris - Hôpital Henri Mondor
-
Contact:
- Anne-Catherine BACHOUD-LEVI, MD,PHD
- Phone Number: +33 01 49 81 23 10
- Email: anne-catherine.bachoud-levi@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age: between 18 and 85 years old
- Inpatient in the initial phase of stroke (between 0 and 21 days after stroke)
- Hemispheric stroke, ischemic or haemorrhagic
- Ability to participate in tests
- Francophone
- 4≤ NIHSS score ≤21 or if NIHSS score < 4, LAST score [0-13]
- Non-opposition to participation in tests
Exclusion Criteria:
- Severe alertness impairment incompatible with test participation, NIHSS score 1a. different from 0
- Severe overall intellectual deterioration incompatible with test participation
- Patients who may have a visual or hearing impairment incompatible with participation in CALAP
- History of stroke
- Posterior fossa stroke
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Language recovery prediction with Core Assessment of Language Processing score
Time Frame: 18 months after stroke
|
the objective is to predict from stroke patient's language performance in the acute phase, his or her language performance in the late phase
|
18 months after stroke
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improving CALAP recovery prediction using MRI data
Time Frame: 18 months after stroke
|
Improvement of the predictive value of the CALAP score in the acute phase using brain MRI data (lesion volume, lesion location, and/or percentage of disconnected fibers measured by MRI).
|
18 months after stroke
|
|
Improving CALAP recovery prediction using neuropsychological data
Time Frame: 18 months after stroke
|
Improvement of the predictive value of the CALAP score in the acute phase using neuropsychological assessment data collected in the acute phase.
|
18 months after stroke
|
|
Cognitive recovery prediction with Core Assessment of Language Processing score
Time Frame: 18 months after stroke
|
The objective is to predict cognitive abilities at the chronic phase based on language performance in the acute phase
|
18 months after stroke
|
|
Improving CALAP recovery prediction using language rehabilitation data
Time Frame: 18 months after stroke
|
The objective is to assess whether language rehabilitation modifies the predictive power of the language abilities assessed with the CALAP
|
18 months after stroke
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP220542
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke Patients
-
Riphah International UniversityCompletedStroke PatientsPakistan
-
Riphah International UniversityNot yet recruitingChronic Stroke PatientsPakistan
-
HealthPartners InstituteRecruitingChronic Stroke PatientsUnited States
-
Southwest Hospital, ChinaRecruitingAcute Ischemic Stroke PatientsChina
-
Biruni UniversityCompletedChronic Stroke Patients | Stroke PatientsTurkey (Türkiye)
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of Kansas Medical CenterNot yet recruitingStroke | Chronic Stroke Patients | Chronic Stroke SurvivorsUnited States
-
Erasme University HospitalFonds Erasme pour la Recherche MédicaleCompletedStroke PatientsBelgium
-
National Cheng-Kung University HospitalCompletedStroke | Stroke PatientsTaiwan
-
Magnetic TidesNational Institute of Neurological Disorders and Stroke (NINDS); University...RecruitingStroke | Arm Weakness as a Consequence of Stroke | Chronic Stroke PatientsUnited States
Clinical Trials on Data recovery from language and cognitive assessment
-
Conor MartinBetsi Cadwaladr University Health BoardUnknownCognitive Impairment - e.g. DementiaUnited Kingdom
-
Sheba Medical CenterUnknown
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloUnknownApraxia | Rolandic EpilepsyBrazil
-
Samsung Medical CenterActive, not recruitingIntellectual Disability | Borderline Intellectual Functioning (BIF)South Korea
-
Hamad Medical CorporationCompletedRenal InsufficiencyQatar
-
Centre Psychothérapique de NancyRecruitingSchizophrenia | Language Disorders | Psychosis | At-risk Mental StateFrance
-
Superior UniversityActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of Massachusetts, WorcesterBoston University; National Institute on Deafness and Other Communication Disorders... and other collaboratorsCompletedParkinson Disease | Cognitive Impairment, Mild | SpeechUnited States
-
Mark WilliamsUniversity of Pennsylvania; University of Illinois at Chicago; Boston Medical... and other collaboratorsCompletedCare TransitionsUnited States